Strides Pharma Science Ltd Quarterly Results
Q3 FY25-26 Results Summary
Revenue
The revenue stands at ₹1,194.65 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 2.14 per cent from ₹1,220.83 crore. This corresponds to a year-on-year *(YoY) growth of 3.55 per cent.
Operating Profit
Operating Profit stands at ₹150.24 crore, reflecting a quarter-on-quarter *(QoQ) increase of 105.05 per cent from ₹73.27 crore. This corresponds to a year-on-year *(YoY) growth of 155.73 per cent.
PBDT
PBDT stands at ₹87.98 crore, reflecting a quarter-on-quarter *(QoQ) increase of 23.52 per cent from ₹71.23 crore. This corresponds to a year-on-year *(YoY) growth of 21.82 per cent.
Profit Before Tax
Profit Before Tax stands at ₹245.49 crore, reflecting a quarter-on-quarter *(QoQ) increase of 60.34 per cent from ₹153.11 crore. This corresponds to a year-on-year *(YoY) growth of 115.64 per cent.
Net Profit
Net Profit stands at ₹205.41 crore, reflecting a quarter-on-quarter *(QoQ) increase of 50.70 per cent from ₹136.30 crore. This represents a 127.27 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Strides Pharma Science Ltd News
Strides Pharma Science Ltd Earnings
- YOY
- QOQ
Strides Pharma Science Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Strides Pharma Science Ltd Research Reports
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
Strides Pharma Science Ltd Financial Reports
Strides Pharma Science Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Strides Pharma | -1.02% | 1.44% | 5.37% | -2.78% | -0.78% | 33.18% |
| Sanofi India | -0.36% | 0.64% | -0.50% | -10.84% | -23.76% | -20.80% |
| Jeena Sikho | -0.81% | 0.41% | -0.94% | 0.13% | -3.45% | 29.13% |
| P & G Health Ltd | -0.64% | -1.62% | -7.81% | -14.65% | -21.45% | -5.88% |
| Marksans Pharma | -0.73% | -1.34% | 4.23% | -8.14% | -2.73% | -22.11% |
| Akums Drugs | -0.10% | 1.02% | 14.65% | 14.13% | 0.00% | -3.06% |
| Sudeep Pharma | -1.44% | 0.92% | 23.34% | -13.95% | -13.95% | -13.95% |
Company Info
Company Information
Executive Chairman & Managing Director : Arun Kumar
Company Sec. & Compli. Officer : Manjula Ramamurthy
Non Executive & Independent Director : Homi Rustam Khusrokhan
Managing Director & Group CEO : Badree Komandur
Non Executive & Independent Director : Kausalya Santhanam
Non Executive & Independent Director : Subir Chakraborty
Non Executive & Independent Director : Ameet Hariani
Director (Business Development) : Aditya Kumar
Independent Director : Mukta Malik Arora